CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure

International Journal of Medical Sciences

Volumn 9, Issue 7, 2012, Pages 592-602

  Liu, Te ^a,b,e   Huang, Yongyi ^e   Guo, Lihe ^c,e   Cheng, Weiwei ^b   Zou, Gang ^d  

^a SHANGHAI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^e Sino America United Stem Cell Research Center   (China)

Author keywords

Cell transplantation; Human amniotic fluid cells; Long term survival; Mesenchymal stem cell like cells; Mouse premature ovarian failure model; Proliferation

Indexed keywords

CELL MARKER; CYCLOPHOSPHAMIDE; ENDOGLIN; HERMES ANTIGEN; KI 67 ANTIGEN; RED FLUORESCENT PROTEIN; SURVIVIN;

AMNIOTIC FLUID CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CYCLE; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OVARY INSUFFICIENCY; PREMATURE OVARY FAILURE; TISSUE SECTION;

AMNIOTIC FLUID; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL SEPARATION; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PRIMARY OVARIAN INSUFFICIENCY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE;

EID: 84866532873     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4841     Document Type: Article

References (21)

1. Bandyopadhyay S, Chakrabarti J, Banerjee S, Pal AK, Goswami SK, Chakravarty BN, et al. Galactose toxicity in the rat as a model for premature ovarian failure: an experimental approach readdressed. Hum Reprod. 2003; 18: 2031-2038.
2. McGuire MM, Bowden W, Engel NJ, Ahn HW, Kovanci E, Rajkovic A. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. Fertil Steril. 2010; 95: 1595-1600
3. Duncan M, Cummings L, Chada K. Germ cell deficient (gcd) mouse as a model of premature ovarian failure. Biol Reprod. 1993; 49: 221-227.
4. Lee HJ, Selesniemi K, Niikura Y, Niikura T, Klein R, Dombkowski DM, et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol. 2007; 25: 3198-3204.
5. Yucebilgin MS, Terek MC, Ozsaran A, Akercan F, Zekioglu O, Isik E, et al. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol. 2004; 44: 6-9.
6. Rebar RW. Premature ovarian failure in the adolescent. Ann N Y Acad Sci. 2008; 1135: 138-145.
7. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006; 1: 9.
8. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010; 45: 257-279.
9. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod. 2003; 18: 1489-1493.
10. Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001; 36: 1662-1665.
11. De Coppi P, Bartsch G, Jr., Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007; 25: 100-106.
12. Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G, Hengstschlager M. Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med. 2005; 16: 987-992.
13. Lin HT, Chiou SH, Kao CL, Shyr YM, Hsu CJ, Tarng YW, et al. Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting. World J Gastroenterol. 2006; 12: 4529-4535.
14. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004; 19: 1450-1456.
15. Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006; 16: 329-336.
16. In 'T Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003; 102: 1548-1549.
17. Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet. 2009; 18: 4340-4349.
18. Liu T, Xu F, Du X, Lai D, Zhao Y, Huang Q, et al. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem. 2010; 340: 265-273.
19. Liu T, Zou G, Gao Y, Zhao X, Wang H, Huang Q, et al. High Efficiency of Reprogramming CD34(+) Cells Derived from Human Amniotic Fluid into Induced Pluripotent Stem Cells with Oct4. Stem Cells Dev. 2012; 21: 2322-2332.
20. Liu T, Guo L, Liu Z, Huang Y, Cheng W. Induction of dopaminergic neuronal-like cells from CD44+ human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model. Int J Mol Med. 2011; 28: 745-752.
21. Zou G, Liu T, Zhang L, Liu Y, Li M, Du X, et al. Induction of pancreatic beta-cell-like cells from CD44+/CD105+ human amniotic fluids via epigenetic regulation of the pancreatic and duodenal homeobox factor 1 promoter. DNA Cell Biol. 2010; 30: 739-748.